INNOVISION
INNOVISIONVerifiedINNOVISION is a publicly traded security listed on the NSE/BSE exchange.
Stock Snapshot & Key Numbers — INNOVISION
Verified Daily CloseOfficial closing price, 1-year price range, valuation multiples, and market value from exchange records.
INNOVISION (INNOVISION) is a Indian equity security listed on the NSE/BSE with ISIN BSE:544732. As of the last recorded market session on Close on 16 Oct 2026, the stock closed at ₹252.80, recording a +1.80 (+0.72%) advance from its previous close of ₹251.00. Over the trailing 52-week trading cycle, INNOVISION has traded between a 52-week low of ₹247.25 and a 52-week high of ₹376.70, establishing its annual trading channel. In historical performance, INNOVISION has fallen 32.44% over the past 1 year. Period returns across standard measurement intervals include: 1-week: +0.28%, 1-month: -1.04%, 6-month: -20.76%, 1-year: -32.44%, 3-year: -32.44%, 5-year: -32.44%. Daily reported trading volume reached 9,384 equity shares. On key valuation multiples as of 11 Oct 2026, the company trades at a trailing price-to-earnings (P/E) multiple of 15.0x and a price-to-book (P/B) ratio of 4.7x, with a trailing dividend yield of 0.00%. Its market capitalization stands at ₹600.33 Cr. The company is categorized under the Diversified Indian Equities sector and Public Market Listed Security industry within the Indian equities universe.
Price Chart
Trading Multiples & Ranges
Price boundaries and liquidity distribution.
How Outside Factors Affect This Stock (Market, Crude Oil & Currency)
How closely this stock moved with the broader market index, crude oil, and the exchange rate over the past year.
| Factor / Benchmark | 1Y Beta (Sensitivity) | 1Y Correlation (-1 to +1) | What This Means |
|---|---|---|---|
| NIFTY 50 | +0.68 | +0.26 | Trailing 1Y historical sensitivity: a 1% move in NIFTY 50 coincided with a +0.68% co-movement (correlation: 0.26). Descriptive historical relationship, not predictive. |
| USD / INR | +0.08 | +0.02 | Trailing 1Y historical sensitivity: a 1% move in USD / INR coincided with a +0.08% co-movement (correlation: 0.02). Descriptive historical relationship, not predictive. |
| Brent Crude Oil | -0.07 | -0.11 | Trailing 1Y historical sensitivity: a 1% move in Brent Crude Oil coincided with a -0.07% co-movement (correlation: -0.11). Descriptive historical relationship, not predictive. |
| US 10Y Treasury Yield | -0.02 | -0.01 | Trailing 1Y historical sensitivity: a 1% move in US 10Y Treasury Yield coincided with a -0.02% co-movement (correlation: -0.01). Descriptive historical relationship, not predictive. |
How to read Beta & Correlation ( Beta > 1 = wider swings than market; < 1 = calmer )▾
Sensitivities measure historical 1-year regression beta and correlation across paired daily trading sessions over the past 252 trading days. Past relationships can shift over time and do not guarantee future co-movement.
Trailing Returns Breakdown
Calendar-aligned historical percentage performance across standard market windows.
| Period | Start Price | Current Price | Return (%) |
|---|---|---|---|
| 1 Week | ₹252.10 | ₹252.80 | +0.28% |
| 15 Days | ₹253.00 | ₹252.80 | -0.08% |
| 1 Month | ₹255.45 | ₹252.80 | -1.04% |
| 3 Months | ₹291.65 | ₹252.80 | -13.32% |
| 6 Months | ₹319.05 | ₹252.80 | -20.76% |
| 1 Year | ₹374.20 | ₹252.80 | -32.44% |
| 3 Years | ₹374.20 | ₹252.80 | -32.44% |
| 5 Years | ₹374.20 | ₹252.80 | -32.44% |
Price Swings & Biggest Historical Drops
How much this stock typically fluctuates and its largest peak-to-bottom drops over 1 and 5 years.
Calendar-Year Historical Performance
Annual performance breakdown comparing first and last closing sessions of each calendar year.
| Calendar Year | Start Close | End Close | Annual Return | Trajectory Bar |
|---|---|---|---|---|
| CY 2026 | ₹374.20 | ₹252.80 | -32.4% |
Historical Investment Simulator
Factual simulation of past returns in INNOVISION (INNOVISION) using real recorded closing prices.
Corporate Actions History
No dividend or stock split distributions recorded in historical feeds for INNOVISION.
Recent News & Official Exchange Announcements
Official exchange filings, order wins, and company updates. Click any announcement to see how it affects the business on the right.
Innovision shares surges 16% on NHAI toll collection contract in Madhya Pradesh - Moneycontrol.com
Innovision shares surges 16% on NHAI toll collection contract in Madhya Pradesh Moneycontrol.com
Innovision Q1 Results: Net loss widens to ₹73.55 million - scanx.trade
Innovision Q1 Results: Net loss widens to ₹73.55 million scanx.trade
Innovision Q1 Results FY27: Revenue Rs 263 crore, Net Loss Rs 7 Crore on Consolidated Basis - Univest
Innovision Q1 Results FY27: Revenue Rs 263 crore, Net Loss Rs 7 Crore on Consolidated Basis Univest
Innovision targets 50-60% revenue CAGR for FY27-FY29 - scanx.trade
Innovision targets 50-60% revenue CAGR for FY27-FY29 scanx.trade
Stocks to Watch Today: Biocon, Fermenta Biotech, Shadowfax, Innovision, Enviro Infra Engineers, Moschip... - Moneycontrol.com
Stocks to Watch Today: Biocon, Fermenta Biotech, Shadowfax, Innovision, Enviro Infra Engineers, Moschip... Moneycontrol.com
Why This Matters for the Business
Plain-English breakdown of how the selected announcement connects to revenue, costs, and business drivers.
Verified commercial order win accretive to order-to-bill ratio, securing multi-quarter top-line visibility.
- •Direct quantitative change registered at 16%
- •Commercial agreement or tender award verified via exchange filing
Volume throughput absorbs fixed manufacturing plant overheads, supporting operating EBITDA margins and cash generation across diversified indian equities units.
Continuous commercial tenders and capital expenditures lock in forward order book-to-bill expansion.
At-a-Glance Health & Momentum Check
While recent announcements reflect past operations, profit margins and return on capital have been tightening as the business absorbs higher costs or new expansion spending.
Peer & Sector Comparison — Next Research Steps
Exit points and comparative equity universe: same-sector peers, shared macro sensitivity betas, and your watchlist.
Common Questions About INNOVISION (INNOVISION)
Key facts on INNOVISION share price, historical returns, valuation ratios, and past SIP performance.
What is the current share price and 52-week range of INNOVISION (INNOVISION)?
As of 16 Oct 2026, the official closing share price of INNOVISION (INNOVISION) on NSE/BSE is ₹252.80 (+0.72% vs the previous close). Over the past 52 weeks, INNOVISION has traded between a low of ₹247.25 and a high of ₹376.70, with a reported market capitalization of ₹600.33 Cr.
What are the historical returns of INNOVISION (INNOVISION)?
Based on split-adjusted closing prices through 16 Oct 2026, INNOVISION (INNOVISION) recorded the following trailing price returns: 1 Week: +0.28% (from ₹252.10 to ₹252.80); 15 Days: -0.08% (from ₹253.00 to ₹252.80); 1 Month: -1.04% (from ₹255.45 to ₹252.80); 3 Months: -13.32% (from ₹291.65 to ₹252.80); 6 Months: -20.76% (from ₹319.05 to ₹252.80); 1 Year: -32.44% (from ₹374.20 to ₹252.80); 3 Years: -32.44% (from ₹374.20 to ₹252.80); 5 Years: -32.44% (from ₹374.20 to ₹252.80). Past performance reflects historical exchange records and does not predict future returns.
What is the P/E ratio, P/B ratio, and dividend yield of INNOVISION (INNOVISION)?
INNOVISION (INNOVISION) currently trades at a trailing Price-to-Earnings (P/E) ratio of 15.0x, a Price-to-Book (P/B) ratio of 4.7x, and a trailing 12-month dividend yield of 0.00%. It operates in the Diversified Indian Equities sector (Public Market Listed Security).
How much would a past lump-sum or monthly SIP investment in INNOVISION have grown?
Based on historical closing prices for INNOVISION (INNOVISION): A one-time lump-sum investment of ₹1,00,000.00 held for 5 years would be worth ₹67,557.45 (-32.4% total return, -49.9% CAGR), while a monthly SIP of ₹10,000.00 over 5 years (total invested: ₹80,000.00) would be worth ₹67,838.92 (-15.2% absolute return). You can test custom amounts and holding periods in the interactive calculator above.
Official Corporate Perspective
Authorized Investor Relations officers may submit authenticated context or coordinate with our research team.